Acknowledgements
This work was supported by funding from the NIMR Biomedical Research Centre.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Goldman, J., Gale, R. What does MRD in leukemia really mean?. Leukemia 28, 1131 (2014). https://doi.org/10.1038/leu.2013.318
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.318
- Springer Nature Limited
This article is cited by
-
Professor Anton Hagenbeek 1948–2021: Father of MRD and lymphoma expert
Bone Marrow Transplantation (2021)
-
Prof. Anton Hagenbeek 1948–2021: Father of MRD and Lymphoma Expert
Leukemia (2021)
-
The not so new history of storing bone marrow
Bone Marrow Transplantation (2020)
-
Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia
Current Treatment Options in Oncology (2019)
-
Measurable residual disease testing in acute myeloid leukaemia
Leukemia (2017)